CLINICAL_TRIALS
trial_result
· 2021-11-01
Clinical Trial Update: Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial evaluated sirolimus for cognitive impairment in Sturge-Weber syndrome; the study has been completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anne Comi, MD | Conditions: Sturge-Weber Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-11-01